Blodgett Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.53M Buy
3,779
+20
+0.5% +$20.4K 3.04% 7
2026
Q1
$3.46M Sell
3,759
-438
-10% -$444K 2.74% 9
2025
Q4
$4.51M Sell
4,197
-255
-6% -$244K 3.15% 7
2025
Q3
$3.4M Sell
4,452
-155
-3% -$115K 2.34% 10
2025
Q2
$3.59M Sell
4,607
-415
-8% -$322K 2.81% 8
2025
Q1
$4.15M Sell
5,022
-125
-2% -$104K 3.53% 7
2024
Q4
$3.97M Buy
5,147
+782
+18% +$648K 3.12% 8
2024
Q3
$3.87M Buy
4,365
+35
+0.8% +$31.5K 3.25% 7
2024
Q2
$3.92M Buy
4,330
+2
+0% +$1.6K 3.32% 7
2024
Q1
$3.37M Buy
4,328
+879
+25% +$626K 3.04% 7
2023
Q4
$2.01M Sell
3,449
-30
-0.9% -$17.5K 2.05% 8
2023
Q3
$1.87M Sell
3,479
-105
-3% -$54.1K 2.05% 9
2023
Q2
$1.68M Sell
3,584
-283
-7% -$119K 1.74% 14
2023
Q1
$1.33M Hold
3,867
1.54% 18
2022
Q4
$1.41M Hold
3,867
1.72% 16
2022
Q3
$1.25M Buy
3,867
+250
+7% +$79.2K 1.5% 18
2022
Q2
$1.17M Sell
3,617
-800
-18% -$240K 1.29% 21
2022
Q1
$1.26M Buy
4,417
+180
+4% +$46.3K 1.05% 24
2021
Q4
$1.17M Buy
+4,237
New +$1.07M 0.91% 27

Other funds holding LLY

Blodgett Wealth Advisors's LLY Position: Q2 2026 in Review

Blodgett Wealth Advisors increased its Eli Lilly (LLY) stake by 0.53% in Q2 2026, buying an estimated $20.4K and bringing the position to 3,779 shares worth $4.53M. The position accounts for 3.04% of the portfolio, ranked #7.

Blodgett Wealth Advisors first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Blodgett Wealth Advisors held 3,779 shares of Eli Lilly worth $4.53M as of Q2 2026.
  • Blodgett Wealth Advisors bought 20 Eli Lilly shares in Q2 2026, an estimated $20.4K.
  • Eli Lilly made up 3.04% of Blodgett Wealth Advisors's portfolio in Q2 2026, its #7 holding.
  • Blodgett Wealth Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Blodgett Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.